Cited by 286HIV-related health complications and treatmentsHIV Research and TreatmentLipid metabolism and disorders

The DOI matches its Crossref record; 59 of the 61 references it cites were found in a registry or an index.

Circulating interferon-α levels and hypertriglyceridemia in the acquired immunodeficiency syndrome.

Grunfeld, Carl, Kotler, Donald P., Shigenaga, Judy Kwan, Doerrler, William, Tierney, Anita, Wang, Jack, Pierson, Richard N., Feingold, Kenneth R.·1991·The American Journal of Medicine

DOI 10.1016/0002-9343(91)90536-7

Open this paper in CoChat — free account

Integrity signals

Registry

Crossref · 10.1016/0002-9343(91)90536-7

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Enzymatic determination of total serum cholesterol.
Allain, C. C., Poon, L. S., Chan, C. S. G., Richmond, W., & Fu, P. C. (1974) · Clinical Chemistry · doi:10.1093/clinchem/20.4.470 · Cited by 9,845
Detection of circulating tumor necrosis factor after endotoxin administration
Michie, H. R., Manogue, K. R., Spriggs, D. R., Revhaug, A., O'Dwyer, S., Dinarello, C. A., Cerami, A., Wolff, S. M., & Wilmore, D. W. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806093182301 · Cited by 1,677
Cachectin: More Than a Tumor Necrosis Factor
Epstein, F. H., Beutler, B., & Cerami, A. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702123160705 · Cited by 1,423
A colorimetric method for estimating serum triglycerides
Fletcher, M. J. (1968) · Clinica Chimica Acta · doi:10.1016/0009-8981(68)90041-7 · Cited by 1,133
Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome
Lähdevirta, J., Maury, C. P. J., Teppo, A., & Repo, H. (1988) · The American Journal of Medicine · doi:10.1016/0002-9343(88)90576-1 · Cited by 717
Tumour necrosis factors α and β inhibit virus replication and synergize with interferons
Wong, G. H., & Goeddel, D. V. (1986) · Nature · doi:10.1038/323819a0 · Cited by 707
Serological Analysis of a Subgroup of Human T-Lymphotropic Retroviruses (HTLV-III) Associated with AIDS
Schüpbach, J., Popovič, M., Gilden, R. V., Gonda, M. A., Sarngadharan, M. G., & Gallo, R. C. (1984) · Science · doi:10.1126/science.6200937 · Cited by 610
Cytokine appearance in human endotoxemia and primate bacteremia.
HESSE, D. G., Tracey, K. J., Fong, Y., Manogue, K. R., Palladino, M. A., Cerami, A., Shires, G. T., & Lowry, S. F. (1988) · PubMed · Cited by 532
The Acquired Immunodeficiency Syndrome
Gottlieb, M. S., Groopman, J. E., WEINSTEIN, W. M., FAHEY, J. L., & DETELS, R. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-99-2-208 · Cited by 471
Systemic Lupus Erythematosus: Presence in Human Serum of an Unusual Acid-Labile Leukocyte Interferon
Preble, O. T., Black, R. J., Friedman, R. M., Klippel, J. H., & Vilček, J. (1982) · Science · doi:10.1126/science.6176024 · Cited by 458

Show all 61 references

Research works printed but not linked: 1

Centers for Disease Control, 1987, Revision of the CDC surveilance case definition for acquired immunodeficiency syndrome, MMWR, 36, 3S

Sorted by citations

Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline
Berglund, L., Brunzell, J. D., Goldberg, A. C., Goldberg, I. J., Sacks, F., Murad, M. H., & Stalenhoef, A. F. H. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3213 · Cited by 887
Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome
Grünfeld, C., Pang, M., Doerrler, W. T., Shigenaga, J. K., Jensen, P., & Feingold, K. R. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.74.5.1373735 · Cited by 845
Self-citation
Impact of HIV infection and HAART on serum lipids in men
Riddler, S. A. (2003) · JAMA · doi:10.1001/jama.289.22.2978 · Cited by 624
Guidelines for the Evaluation and Management of Dyslipidemia in Human Immunodeficiency Virus (HIV)-Infected Adults Receiving Antiretroviral Therapy: Recommendations of the HIV Medicine Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group
Dubé, M. P., Stein, J. H., Aberg, J. A., Fichtenbaum, C. J., Gerber, J. G., Tashima, K. T., Henry, W. K., Currier, J. S., Sprecher, D. L., & Glesby, M. J. (2003) · Clinical Infectious Diseases · doi:10.1086/378131 · Cited by 578
Inflammation and cardiovascular disease: From mechanisms to therapeutics
Alfaddagh, A., Martin, S. S., Leucker, T. M., Michos, E. D., Blaha, M. J., Lowenstein, C. J., Jones, S. R., & Toth, P. P. (2020) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2020.100130 · Cited by 473
Infection and Inflammation‐Induced Proatherogenic Changes of Lipoproteins
Khovidhunkit, W., Memon, R. A., Feingold, K. R., & Grünfeld, C. (2000) · The Journal of Infectious Diseases · doi:10.1086/315611 · Cited by 403
Self-citation
Metabolic Disturbances and Wasting in the Acquired Immunodeficiency Syndrome
Flier, J. S., Underhill, L. H., Grunfeld, C., & Feingold, K. R. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207303270506 · Cited by 398
Self-citation
Energy Expenditure and Wasting in Human Immunodeficiency Virus Infection
Macallan, D. C., Noble, C., Baldwin, C., Jebb, S. A., Prentice, A. M., Coward, W. A., Sawyer, M. B., McManus, T. J., & Griffin, G. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507133330202 · Cited by 391
Measurement of de novo hepatic lipogenesis in humans using stable isotopes.
Hellerstein, M. K., Christiansen, M., Kaempfer, S., Kletke, C., Wu, K. K., Reid, J., Mulligan, K. M., Hellerstein, N. S., & Shackleton, C. H. L. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115206 · Cited by 362
Fat distribution and metabolic changes in patients with HIV infection
Safrin, S., & Grünfeld, C. (1999) · AIDS · doi:10.1097/00002030-199912240-00002 · Cited by 358
LDL subclass phenotypes and triglyceride metabolism in non-insulin-dependent diabetes.
Feingold, K. R., Grünfeld, C., Pang, M., Doerrler, W. T., & Krauss, R. M. (1992) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.12.12.1496 · Cited by 302
Self-citation
Resting energy expenditure, caloric intake, and short-term weight change in human immunodeficiency virus infection and the acquired immunodeficiency syndrome
Grünfeld, C., Pang, M., Shimizu, L., Shigenaga, J. K., Jensen, P., & Kr, F. (1992) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/55.2.455 · Cited by 278
Self-citation
Blood‐brain barrier abnormalities in acquired immunodeficiency syndrome: Immunohistochemical localization of serum proteins in postmortem brain
Petito, C. K., & Cash, K. S. (1992) · Annals of Neurology · doi:10.1002/ana.410320509 · Cited by 276
Clinical Toxicity of the Interferons
Vial, T., & Descotes, J. (1994) · Drug Safety · doi:10.2165/00002018-199410020-00003 · Cited by 267
Increased de novo hepatic lipogenesis in human immunodeficiency virus infection
Hellerstein, M. K., Grünfeld, C., Wu, K. K.-Y., Christiansen, M., Kaempfer, S., Kletke, C., & Shackleton, C. H. L. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.3.8445011 · Cited by 242
State of the Science Conference
Grinspoon, S. K., Grünfeld, C., Kotler, D. P., Currier, J. S., Lundgren, J. D., Dubé, M. P., Lipshultz, S. E., Hsue, P. Y., Squires, K., Schambelan, M., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.189622 · Cited by 230
Self-citation
Endocrine and Metabolic Disturbances in Human Immunodeficiency Virus Infection and the Acquired Immune Deficiency Syndrome*
Sellmeyer, D. E., & Grünfeld, C. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-5-518 · Cited by 227
HIV Disease and the Endocrine System
Desforges, J. F., Grinspoon, S. K., & Bilezikian, J. P. (1992) · New England Journal of Medicine · doi:10.1056/nejm199211053271906 · Cited by 226
Hypocholesterolemia is associated with immune dysfunction in early human immunodeficiency virus-1 infection
Shor‐Posner, G., Basit, A., Lü, Y., Cabrejos, C., Chang, J., Fletcher, M., Mantero-Atienza, E., & Baum, M. K. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90087-6 · Cited by 197
Preliminary Guidelines for the Evaluation and Management of Dyslipidemia in Adults Infected with Human Immunodeficiency Virus and Receiving Antiretroviral Therapy: Recommendations of the Adult AIDS Clinical Trial Group Cardiovascular Disease Focus Group
Mayer, K. H., Dubé, M. P., Sprecher, D. L., Henry, W. K., Aberg, J. A., Torriani, F. J., Hodis, H. N., Schouten, J., Levin, J., Myers, G. L., et al. (2000) · Clinical Infectious Diseases · doi:10.1086/317429 · Cited by 196
Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infection
Wand, H. C., Calmy, A., Carey, D., Samaras, K., Carr, A. D., Law, M. G., Cooper, D. A., & Emery, S. (2007) · AIDS · doi:10.1097/qad.0b013e3282efad32 · Cited by 196
The hypertriglyceridemia of acquired immunodeficiency syndrome is associated with an increased prevalence of low density lipoprotein subclass pattern B.
Kr, F., Krauss, R. M., Pang, M., Doerrler, W. T., Jensen, P. B., & Grünfeld, C. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.6.8501146 · Cited by 182
Self-citation
HIV–Associated Lipodystrophy: Pathogenesis, Prognosis, Treatment, and Controversies
Koutkia, P., & Grinspoon, S. K. (2004) · Annual Review of Medicine · doi:10.1146/annurev.med.55.091902.104412 · Cited by 179
Contribution of Metabolic and Anthropometric Abnormalities to Cardiovascular Disease Risk Factors
Grünfeld, C., Kotler, D. P., Arnett, D. K., Falutz, J., Haffner, S. M., Hruz, P. W., Masur, H., Meigs, J. B., Mulligan, K. M., Reiss, P., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.189623 · Cited by 178
Self-citation
Incidence of Metabolic Syndrome in a Cohort of HIV-Infected Adults and Prevalence Relative to the US Population (National Health and Nutrition Examination Survey)
Jacobson, D. L., Tang, A., Spiegelman, D. L., Thomas, A. M., Skinner, S. C., Gorbach, S. L., & WANKE, C. A. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000243093.34652.41 · Cited by 177
HIV and HAART-Associated Dyslipidemia
Feeney, E. R., & Mallon, P. W. G. (2011) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192401105010049 · Cited by 173
Plasma lipids in HIV‐infected patients: a prospective study in 95 patients
Constans, J., Pellegrin, J., Peuchant, E., Dumon, M. F., Pellegrin, I., Sergeant, C., Simonoff, M., Brossard, G., Barbeau, P., Fleury, H. J., et al. (1994) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1994.tb02185.x · Cited by 172
Immunogenicity of aggregates of recombinant human growth hormone in mouse models
Fradkin, A. H., Carpenter, J. F., & Randolph, T. W. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21834 · Cited by 173
Cutaneous findings in HIV-1-positive patients: A 42-month prospective study
Smith, K. J., Skelton, H. G., Yeager, J. K., Ledsky, R., McCarthy, W., BAXTER, D. L., & Wagner, K. F. (1994) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(94)70236-5 · Cited by 162
Metabolic complications associated with antiretroviral therapy
Jain, R. G., Furfine, E. S., Pedneault, L., White, A. J., & Lenhard, J. M. (2001) · Antiviral Research · doi:10.1016/s0166-3542(01)00148-6 · Cited by 150
Changes in the concentration and composition of plasma lipoproteins during the acute phase response
Carpentier, Y. A., & Scruel, O. (2002) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/00075197-200203000-00006 · Cited by 148
Blood Lipid Measurements
Cooper, G. R. (1992) · JAMA · doi:10.1001/jama.1992.03480120090039 · Cited by 156
Cytokines induce catabolic effects in cultured adipocytes by multiple mechanisms
Doerrler, W. T., Feingold, K. R., & Grünfeld, C. (1994) · Cytokine · doi:10.1016/1043-4666(94)90074-4 · Cited by 137
Self-citation
HIV-associated dyslipidaemia: pathogenesis and treatment
Oh, J., & Hegele, R. A. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70287-6 · Cited by 137
Inflammation in HIV and Its Impact on Atherosclerotic Cardiovascular Disease
Obare, L. M., Temu, T. M., Mallal, S. A., & Wanjalla, C. N. (2024) · Circulation Research · doi:10.1161/circresaha.124.323891 · Cited by 150
Adipocytes Targets and Actors in the Pathogenesis of HIV-Associated Lipodystrophy and Metabolic Alterations
Gougeon, M., Pénicaud, L., Fromenty, B., Leclercq, P., Viard, J., & Capeau, J. (2004) · Antiviral Therapy · doi:10.1177/135965350400900206 · Cited by 129
HIV and Antiretroviral Therapy: Lipid Abnormalities and Associated Cardiovascular Risk in HIV-Infected Patients
Kotler, D. P. (2008) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318186519c · Cited by 128
Self-citation
Hyperlipidemia Associated with HIV Protease Inhibitor Use: Pathophysiology, Prevalence, Risk Factors and Treatment
Penzak, S. K. C. S. R. (2000) · Scandinavian Journal of Infectious Diseases · doi:10.1080/003655400750045196 · Cited by 123
Whole-body protein turnover from leucine kinetics and the response to nutrition in human immunodeficiency virus infection
Macallan, D. C., McNurlan, M. A., Milne, E., Calder, A. G., Garlick, P. J., & Griffin, G. (1995) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/61.4.818 · Cited by 117
Lipodystrophy Syndrome in HIV Infection
Behrens, G. M. N., Stoll, M., & Schmidt, R. E. (2000) · Drug Safety · doi:10.2165/00002018-200023010-00004 · Cited by 107
Elevated resting energy expenditure among HIV-seropositive persons receiving highly active antiretroviral therapy
Shevitz, A., Knox, T. A., Spiegelman, D. L., Roubenoff, R., Gorbach, S. L., & Skolnik, P. R. (1999) · AIDS · doi:10.1097/00002030-199907300-00012 · Cited by 100
The Role of Protease Inhibitors in the Pathogenesis of HIV-Associated Lipodystrophy: Cellular Mechanisms and Clinical Implications
Flint, O. P., Noor, M. A., Hruz, P. W., Hylemon, P. B., Yarasheski, K. E., Kotler, D. P., Parker, R. A., & Bellamine, A. (2009) · Toxicologic Pathology · doi:10.1177/0192623308327119 · Cited by 101
Self-citation
Endogenous interferon and triglyceride concentrations to assess response to zidovudine in AIDS and advanced AIDS-related complex
Mildvan, D., Wilets, I. F., Machado, S. G., & Grossberg, S. E. (1992) · The Lancet · doi:10.1016/0140-6736(92)91058-g · Cited by 101
Longitudinal changes in serum lipids among HIV‐infected men on highly active antiretroviral therapy
Riddler, S., Li, X., Chu, H., Kingsley, L., Dobs, A. S., Evans, R., Palella, F. J., Visscher, B. R., Chmiel, J. S., & Sharrett, A. (2007) · HIV Medicine · doi:10.1111/j.1468-1293.2007.00470.x · Cited by 99
Thyroid function in human immunodeficiency virus patients treated with highly active antiretroviral therapy (HAART): a longitudinal study
Madeddu, G., Spanu, A., Chessa, F., Calia, G. M., Lovigu, C., Solinas, P., Mannazzu, M., Falchi, A., Mura, M. S., & Madeddu, G. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02472.x · Cited by 97
Differential Roles of Extracellular Signal-regulated Kinase-1/2 and p38MAPK in Interleukin-1β- and Tumor Necrosis Factor-α-induced Low Density Lipoprotein Receptor Expression in HepG2 Cells
Kumar, A., Middleton, A., Chambers, T. C., & Mehta, K. D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.25.15742 · Cited by 97
Lipid profile of HIV-infected patients in relation to antiretroviral therapy: a review
Souza, S. J., Luzia, L. A., dos Santos, S. D. S., & Rondó, P. H. D. C. (2013) · Revista da Associação Médica Brasileira · doi:10.1016/j.ramb.2012.11.003 · Cited by 93
Blood lipids of patients with chronic hepatitis: differences related to viral etiology
Fabris, C., Federico, E., Soardo, G., Falleti, E., & Pirisi, M. (1997) · Clinica Chimica Acta · doi:10.1016/s0009-8981(97)06532-7 · Cited by 88
Hyperlipidaemia in patients with HIV-1 infection receiving highly active antiretroviral therapy: epidemiology, pathogenesis, clinical course and management
Calza, L., Manfredi, R., & Chiodo, F. (2003) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(03)00115-8 · Cited by 83
Hypofibrinolytic State in HIV-1–Infected Patients Treated With Protease Inhibitor–Containing Highly Active Antiretroviral Therapy
Koppel, K., Bratt, G., Schulman, S., Bylund, H., & Sandström, E. (2002) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200204150-00003 · Cited by 83
Dysregulation of glucose metabolism in HIV patients: epidemiology, mechanisms, and management
Gutierrez, A., & Balasubramanyam, A. (2011) · Endocrine · doi:10.1007/s12020-011-9565-z · Cited by 83
Seborrhoeic dermatitis is not caused by an altered immune response to Malassezia yeast: MALASSEZIA IMMUNITY IN SEBORRHOEIC DERMATITIS
Parry, & Sharpe (1998) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1998.02362.x · Cited by 82
Acute effects of interferon-alpha administration on thyroid hormone metabolism in healthy men
Corssmit, E. P. M., Heyligenberg, R., Endert, E., Sauerwein, H. P., & Romijn, J. A. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.11.7593416 · Cited by 82
Protease inhibitor-based HAART, HDL, and CHD-risk in HIV-infected patients
Asztalos, B. F., Schaefer, E. J., Horvath, K. V., Cox, C. E., Skinner, S. C., Gerrior, J., Gorbach, S. L., & WANKE, C. A. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.04.013 · Cited by 80
Cardiovascular disease in HIV-positive patients
Kamin, D., & Grinspoon, S. K. (2005) · AIDS · doi:10.1097/01.aids.0000166087.08822.bc · Cited by 80
The tyrosine kinase inhibitor STI571, like interferon-α, preferentially reduces the capacity for amplification of granulocyte-macrophage progenitors from patients with chronic myeloid leukemia
Marley, S. B., Deininger, M. W., Davidson, R. J., Goldman, J. M., & Gordon, M. Y. (2000) · Experimental Hematology · doi:10.1016/s0301-472x(00)00142-9 · Cited by 79
Antiretroviral Therapy is Associated With an Atherogenic Lipoprotein Phenotype Among HIV-1-Infected Men in the Multicenter AIDS Cohort Study
Riddler, S. A., Li, X., Otvos, J. D., Post, W. S., Palella, F. J., Kingsley, L., Visscher, B. R., Jacobson, L. P., & Sharrett, A. R. (2008) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31817bbbf0 · Cited by 78
Effects of Dietary n-3 Fatty Acid Supplementation in Men with Weight Loss Associated with the Acquired Immune Deficiency Syndrome: Relation to Indices of Cytokine Production
Hellerstein, M. K., Wu, K. K., McGrath, M. S., Faix, D. J., George, D., Shackleton, C. H. L., Horn, W. F., Hoh, R., & Neese, R. A. (1996) · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · doi:10.1097/00042560-199603010-00006 · Cited by 78
Similar changes in plasmacytoid dendritic cell and CD4 T-cell counts during primary HIV-1 infection and treatment
Killian, M. S., Fujimura, S. H., Hecht, F. M., & Levy, J. A. (2006) · AIDS · doi:10.1097/01.aids.0000232231.34253.bd · Cited by 77
Interferons in the pathogenesis and treatment of human immunodeficiency virus infection
Poli, G., Biswas, P., & Fauci, A. S. (1994) · Antiviral Research · doi:10.1016/0166-3542(94)90069-8 · Cited by 78
MALNUTRITION IN HIV INFECTION
Babameto, G. P., & Kotler, D. P. (1997) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(05)70301-0 · Cited by 74
Self-citation
Use of Fibrates in the Management of Hyperlipidemia in HIV-Infected Patients Receiving HAART
Calza, L., Manfredi, R., & Chiodo, F. (2002) · Infection · doi:10.1007/s15010-001-2052-3 · Cited by 72
Leukemia inhibitory factor induces changes in lipid metabolism in cultured adipocytes
Marshall, M. K., Doerrler, W. T., Feingold, K. R., & Grünfeld, C. (1994) · Endocrinology · doi:10.1210/en.135.1.141 · Cited by 72
Self-citation
Hyperlipidemia Associated with Protease Inhibitor Therapy
Echevarria, K. L., Hardin, T. C., & Smith, J. A. (1999) · Annals of Pharmacotherapy · doi:10.1345/aph.18174 · Cited by 72
The Role of the Cytokines, Interferon Alpha and Tumor Necrosis Factor in the Hypertriglyceridemia and Wasting of AIDS ,
Grünfeld, C., & Feingold, K. R. (1992) · Journal of Nutrition · doi:10.1093/jn/122.suppl_3.749 · Cited by 71
Self-citation
Effects of interferon-alpha (IFN-α) administration on leucocytes in healthy humans
Corssmit, E. P. M., Heijligenberg, R., Hack, C. E., Endert, E., Sauerwein, H. P., & Romijn, J. A. (1997) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1997.269-ce1161.x · Cited by 70
Anti-Retroviral Therapy Increases the Prevalence of Dyslipidemia in South African HIV-Infected Patients
Dave, J. A., Levitt, N. S., Ross, I. L., Lacerda, M., Maartens, G., & Blom, D. J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151911 · Cited by 75
Treatment with interferon-alpha preferentially reduces the capacity for amplification of granulocyte-macrophage progenitors (CFU-GM) from patients with chronic myeloid leukemia but spares normal CFU-GM.
Gordon, M. Y., Marley, S. B., Lewis, J. L., Davidson, R. J., Nguyen, D., Grand, F. H., Amos, T. A. S., & Goldman, J. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3094 · Cited by 68
Pathogenesis of Psoriasis: Current Concepts
Kadunce, D. P., & Krueger, G. G. (1995) · Dermatologic Clinics · doi:10.1016/s0733-8635(18)30037-8 · Cited by 66
Postsurgical reduction of serum lipoproteins: Interleukin-6 and the acute-phase response
Akgün, S., Ertel, N. H., Mosenthal, A. C., & Oser, W. (1998) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(98)90083-x · Cited by 65
Stimulation of vitamin A1 acid signaling by the HIV protease inhibitor indinavir
Lenhard, J. M., Weiel, J. E., Paulik, M. A., & Furfine, E. S. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00246-x · Cited by 65
Alterations of Apolipoprotein B Metabolism in HIV-Infected Patients With Antiretroviral Combination Therapy
Schmitz, M., Michl, G. M., Walli, R., Bogner, J. R., Bedynek, A., Seidel, D., Goebel, F. D., & Demant, T. (2001) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200103010-00004 · Cited by 64
Enhancement of tissue glutathione for antioxidant and immune functions in malnutrition
Bray, T. Μ., & Taylor, C. G. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90246-1 · Cited by 61
Nutrition and HIV infection
Salomon, J., de Truchis, P., & Melchior, J. (2002) · British Journal Of Nutrition · doi:10.1079/bjn2001464 · Cited by 60
An endogenous 55 kDa TNF receptor mediates cell death in a neural cell line
Sipe, K. J., Srisawasdi, D., Dantzer, R., Kelley, K. W., & Weyhenmeyer, J. A. (1996) · Molecular Brain Research · doi:10.1016/0169-328x(95)00310-o · Cited by 58
Biologic Responses to IFN-α Administration in Humans
Corssmit, E. P. M., de Metz, J., Sauerwein, H. P., & Romijn, J. A. (2000) · Journal of Interferon & Cytokine Research · doi:10.1089/107999000750053690 · Cited by 57
Targeting Inflammation to Reduce Atherosclerotic Cardiovascular Risk in People With HIV Infection
Titanji, B. K., Gavegnano, C., Hsue, P. Y., Schinazi, R. F., & Marconi, V. C. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.014873 · Cited by 56
Safety and Efficacy of Extended-Release Niacin for the Treatment of Dyslipidaemia in Patients with HIV Infection: Aids Clinical Trials Group Study A5148
Meixner, L., Hoffman, J., Zwickl, B., Goldman, M. H., Whitely, K., Conrad, A., Fichtenbaum, C. J., Hyc, F., Spitz, T., Shaw, D. D., et al. (2006) · Antiviral Therapy · doi:10.1177/135965350601100802 · Cited by 55
NUTRITIONAL ASPECTS OF HIV INFECTION
Nerad, J. L., & Gorbach, S. L. (1994) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(20)30603-6 · Cited by 55
Mechanism of highly active anti-retroviral therapy-induced hyperlipidemia in HIV-infected individuals
Carpentier, A. C., Patterson, B. W., Uffelman, K. D., Salit, I. E., & Lewis, G. F. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.07.035 · Cited by 54
Lipid Metabolism in Treated HIV Infection
Dubé, M. P., & Cadden, J. J. (2011) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2011.04.004 · Cited by 53
Tumor necrosis factor, cytokines, and the hyperlipidemia of infection
Grünfeld, C., & Feingold, K. R. (1991) · Trends in Endocrinology and Metabolism · doi:10.1016/1043-2760(91)90027-k · Cited by 51
Self-citation
Serum Triglycerides, HIV Infection, and Highly Active Antiretroviral Therapy, Aquitaine Cohort, France, 1996 to 1998
Thiébaut, R., Dabis, F., Malvy, D. J.-M., Jacqmin‐Gadda, H., Mercié, P., & Valentin, V. D. (2000) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200003010-00009 · Cited by 52
Nutritional and hormonal regulation of glutathione homeostasis
Taylor, C. G., Nagy, L. E., & Bray, T. Μ. (1996) · Current topics in cellular regulation · doi:10.1016/s0070-2137(96)80007-0 · Cited by 54
Treatment options for hypertriglyceridemia: From risk reduction to pancreatitis
Berglund, L., Brunzell, J. D., Goldberg, A. C., Goldberg, I. J., & Stalenhoef, A. (2014) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.10.002 · Cited by 50
Interactions Between Nutrition and Infection with Human Immunodeficiency Virus
Gorbach, S. L., Knox, T. A., & Roubenoff, R. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1993.tb03110.x · Cited by 50
Lipoprotein alterations in patients with HIV infection: relation with cellular and humoral immune markers
Fernández‐Miranda, C., Pulido, F., Carrillo, J. L., Larumbe, S., Gómez‐Izquierdo, T., Ortuño, B., Rubio, R., & del Palacio, A. (1998) · Clinica Chimica Acta · doi:10.1016/s0009-8981(98)00050-3 · Cited by 49
The effects of HIV protease inhibitors on carbohydrate and lipid metabolism
Lee, G. A., Rao, M. N., & Grünfeld, C. (2005) · Current HIV/AIDS Reports · doi:10.1007/s11904-996-0008-z · Cited by 49
Major loci influencing serum triglyceride levels on 2q14 and 9p21 localized by homozygosity-by-descent mapping in a large Hutterite pedigree
Newman, D. L. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg012 · Cited by 47
Management of Protease Inhibitor-Associated Hyperlipidemia
Penzak, S. R., & Chuck, S. K. (2002) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200202020-00003 · Cited by 46
Endocrine and metabolic effects of interferon-alpha in humans
Corssmit, E. P. M., Heijligenberg, R., Endert, E., Ackermans, M. T., Sauerwein, H. P., & Romijn, J. A. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.9.8784081 · Cited by 46
Amprenavir
Noble, S., & Goa, K. L. (2000) · Drugs · doi:10.2165/00003495-200060060-00012 · Cited by 46
Prevalence of metabolic syndrome in human immunodeficiency virus - infected patients from the South-West region of Cameroon, using the adult treatment panel III criteria
Mbunkah, H. A., Meriki, H. D., Kukwah, A. T., Nlinwe, N. O., & Nkuo-Akenji, T. K. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-92 · Cited by 45
The acute‐phase response and associated lipoprotein abnormalities accompanying lymphoma
Blackman, J. D., Cabana, V. G., & Mazzone, T. (1993) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1993.tb00674.x · Cited by 45
Dyslipidemia in an HIV-Positive Antiretroviral Treatment-Naive Population in Dar es Salaam, Tanzania
Armstrong, C. A., Liu, E., Okuma, J. O., Spiegelman, D. L., Guerino, C., Njelekela, M. A., Grinspoon, S., Fawzi, W. W., & Hawkins, C. (2011) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318219a3d1 · Cited by 44
Cardiovascular Complications of HIV in Endemic Countries
Feinstein, M. J., Bogorodskaya, M., Bloomfield, G. S., Vedanthan, R., Siedner, M. J., Kwan, G. F., & Longenecker, C. T. (2016) · Current Cardiology Reports · doi:10.1007/s11886-016-0794-x · Cited by 48
Serum amyloid A and high‐density lipoprotein cholesterol: serum markers of inflammation in sarcoidosis and other systemic disorders
Salazar, A., Pintó, X., & Mañá, J. (2001) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2001.00913.x · Cited by 44
Dietary Fish Oil and Cytokine and Eicosanoid Production During Human Immunodeficiency Virus Infection
Bell, S. J., Chavali, S. R., Bistrian, B. R., Connolly, C. A., Utsunomiya, T., & Forse, R. A. (1996) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/014860719602000143 · Cited by 44
Endocrinological aspects of HIV infection
Mirza, F., Luthra, P., & Chirch, L. M. (2018) · Journal of Endocrinological Investigation · doi:10.1007/s40618-017-0812-x · Cited by 45
Insulin Resistance and Diabetes Mellitus in HIV-Infected Patients Receiving Antiretroviral Therapy
Calza, L., Manfredi, R., & Chiodo, F. (2004) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2004.2.241 · Cited by 42

Authors: Grunfeld, C., Kotler, D. P., Shigenaga, J. K., Doerrler, W., Tierney, A., Wang, J., Pierson, R. N., & Feingold, K. R.
Affiliations: St. Luke's-Roosevelt Hospital Center (US)
San Francisco VA Medical Center (US)
ORCID: Doerrler, William
Wang, Jack
Pierson, Richard N.
Venue: The American Journal of Medicine
Publisher: Elsevier BV
Published: 1991-01
Volume: 90
Issue: 1
Pages: 154-162
ISSN: 0002-9343 (ISSN-L)
DOI: 10.1016/0002-9343(91)90536-7
OpenAlex: W2074372816
Cited by: 286
References: 61
Citations by year: 2026: 1 · 2025: 1 · 2024: 2 · 2023: 1 · 2022: 3 · 2021: 2 · 2020: 5 · 2019: 3 · 2018: 2 · 2017: 2 · 2016: 3 · 2015: 5 · 2014: 7 · 2013: 8 · 2012: 5
FWCI: 30.44
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: The American Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (2r01ai021414-04a1)
Genentech
National Institute of Allergy and Infectious Diseases (AI-21414)
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK040990, DK-40990)
Topics: Health Sciences › Medicine › Infectious Diseases › HIV-related health complications and treatments
Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
Keywords: interferon-alpha, hypertriglyceridemia, AIDS, HIV infection, cytokines, TNF-α, interleukin-1, wasting, lean body mass, lipid metabolism, serum triglycerides, total body potassium
MeSH terms: Acquired Immunodeficiency Syndrome, Adult, Body Composition, Cholesterol, Humans, Interferon Type I, Interleukin-1, Male, Middle Aged, Potassium, Triglycerides, Tumor Necrosis Factor-alpha, Hypertriglyceridemia, Body Mass Index

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Circulating interferon-α levels and hypertriglyceridemia in the acquired immunodeficiency syndrome.

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks